Probiotics linked with fewer respiratory symptoms in overweight and older people
An Imperial led study, which will be presented at Digestive Disease Week 2021, provides further evidence of a relationship between the gut and lungs.
Video
Drug dosing technology to improve children’s cancer treatment
Imperial's London IVD Co-operative will support the translation of new precise drug dosing technology, ChromaDose, into the NHS healthcare system.
National Phenome Centre expands in to proteomics and imaging
The National Phenome Centre has expanded its purview to include proteomic profiling as well as mass spectrometry imaging capabilities.
World Cancer Day 2021
To coincide with World Cancer Day, we look back at how Imperial College London has been leading the fight against cancer in the past year.
Meet the eLearning Technologists digitising the education rule book - Part 2
A team of eLearning Technologists from the Faculty of Medicine have been working tirelessly to support the digitisation of its Postgraduate courses.
Experts support COVID vaccines for Inflammatory Bowel Disease patients
British Society of Gastroenterology Inflammatory Bowel Disease Section and IBD Clinical Research Group release statement supporting COVID-19 vaccines.
Meet the eLearning Technologists digitising the education rule book - Part 1
A team of eLearning Technologists from the Faculty of Medicine have been working tirelessly to support the digitisation of its Postgraduate courses.
Predicting Wet Macular Degeneration with DARC AI Biomarker
A new study has found that a DARC AI biomarker can predict new wet AMD lesions up to 36 months in advance of them occurring.
NPC leads on metabolic analysis in UK COVID-19 research
The National Phenome Centre (NPC) is playing a supporting role in the UK's leading COVID-19 research consortium.
COVID-19 mortality associated with inflammatory response in NAFLD patients
New research from Imperial looks at how underlying non-alcoholic fatty liver disease (NAFLD) impacts patient’s with COVID-19.
